health · HHS-NIH11
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
National Institutes of Health · PAR-25-064
Deadline
September 7, 2026
GRANTQUICK SUMMARYPlain-English Overview
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional). National Institutes of Health. The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are... Funding amounts not specified.
Who Should Apply
Nonprofits (501c3), County governments, Federally Recognized Native American Tribal Governments, Public And Indian Housing Authorities, Private universities/colleges (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
- •Deadline: 2026-09-07
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
NIH Grants Information grantsinfo@nih.gov
grantsinfo@nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov